{
  "id": "5328185dd6d3ac6a3400000e",
  "type": "yesno",
  "question": "Is metabolic syndrome related with cardiovascular disease?",
  "ideal_answer": "The metabolic syndrome (MetS) is characterized by a cluster of risk factors including central obesity, hypertension, dyslipidemia and insulin resistance, The MetS is associated with an increased risk for cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/18945929",
    "http://www.ncbi.nlm.nih.gov/pubmed/24247648",
    "http://www.ncbi.nlm.nih.gov/pubmed/19196885",
    "http://www.ncbi.nlm.nih.gov/pubmed/24320036",
    "http://www.ncbi.nlm.nih.gov/pubmed/24320031",
    "http://www.ncbi.nlm.nih.gov/pubmed/24287796",
    "http://www.ncbi.nlm.nih.gov/pubmed/24328010",
    "http://www.ncbi.nlm.nih.gov/pubmed/21234418",
    "http://www.ncbi.nlm.nih.gov/pubmed/24320038",
    "http://www.ncbi.nlm.nih.gov/pubmed/24290090"
  ],
  "snippets": [
    {
      "text": "The metabolic syndrome (MetS) is characterized by a cluster of risk factors including central obesity, hypertension, dyslipidemia and insulin resistance, The MetS is associated with an increased risk for cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24320038",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "As a molecular link between metabolic signals, inflammation, and vascular dysfunction, resistin can be proposed as playing a significant role in the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for metabolic syndrome (MetS), type 2 diabetes (T2DM), and cardiovascular disease (CVD). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24320036",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The metabolic syndrome (MetS) is associated with a higher risk for both, type 2 diabetes mellitus and cardiovascular disease. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24320031",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "arotid intima-media thickness (CIMT) has been widely used as a surrogate marker of atherosclerosis and cardiovascular disease (CVD)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24328010",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D024821",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002318",
    "http://www.disease-ontology.org/api/metadata/DOID:14221",
    "http://www.disease-ontology.org/api/metadata/DOID:1287"
  ],
  "exact_answer": "Yes"
}